Chemotherapy-induced Nausea and Vomiting Control

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

For patients (and parents of patients) that have been diagnosed with, pediatric acute lymphoblastic leukemia (ALL), nausea and vomiting are among the most bothersome symptoms during chemotherapy treatment. The overall goal of this study is to find the best strategies used by parents and patients for managing these symptoms when receiving maintenance therapy.

Who Do I Contact?

If you are interested in participating in the study or want to learn more please contact our study team at DIORIOC [at] chop.edu or 267-425-5544.

Eligibility & Criteria

IRB #:
21-018666
Official Title:
Chemotherapy-induced Nausea and Vomiting Control: Understanding Preferences of Pediatric Patients and their Parents
Study Phase:
Not Applicable
Gender:
All
Study Categories:

Visit Criteria

This study will enroll parents/guardians of patients that have been diagnosed with pediatric acute lymphoblastic leukemia (ALL) that are 18 years old and younger and patients that have been diagnosed with ALL that are 13-18 years old. Participants will be invited to share their experience with chemotherapy-induced nausea and vomiting (CINV). Interviews will be conducted in person or virtually using a moderator guide that centers around discussion surrounding CINV management.

Leader
Caitlin Elgarten

Caitlin Elgarten, MD, MSCE